Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1No longer available 1

Sponsor Class

NETWORK 2OTHER 1

Study Type

Interventional 1Expanded_access 1

Sponsor

Cancer Type

CNS 2

Conditions

Prostatic Neoplasms 2Neuroblastoma 2Recurrence 1Ovarian Neoplasms 1

Interventions

Cyclophosphamide 18Vincristine 13Filgrastim 13Doxorubicin 13Carboplatin 13Etoposide 12Granulocyte Colony-Stimulating Factor 10Isotretinoin 9Cisplatin 9Topotecan 8Peripheral Blood Stem Cell Transplantation 8sargramostim 7Melphalan 7Radiotherapy 6etoposide phosphate 5Thiotepa 5Polymerase Chain Reaction 5Platinum 5Magnetic Resonance Spectroscopy 4Irinotecan 4Immunohistochemistry 4Gene Expression Profiling 4Colony-Stimulating Factors 41,2-diaminocyclohexaneplatinum II citrate 4lorukafusp alfa 3dinutuximab 3Temozolomide 3Stem Cell Transplantation 3Specimen Handling 3Radiation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Neuroblastoma × Ketoconazole × Clear all
NCT02163356 2022-03-31

SPOC2013-001

South Plains Oncology Consortium

Phase 1 Terminated
4 enrolled
CNS

Neuroblastoma, Recurrence

NCT02075177 2022-03-21

Expanded Access Study of Fenretinide Lym-X-Sorb Plus Ketoconazole in Neuroblastoma

South Plains Oncology Consortium

No longer available
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡